2021
DOI: 10.1007/s00405-020-06461-2
|View full text |Cite
|
Sign up to set email alerts
|

Nasal mucociliary clearance and hearing loss in pseudoexfoliation syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…In contrast with the above-mentioned results, Muhafiz et al did not find any significant difference in hearing loss prevalence and hearing thresholds at 0.25, 0.5, 1, 2, 4, 6 and 8 kHz between XFS and controls ( p > 0.05) [ 71 ]. Additionally, Tryggvason et al examined hearing loss in 158 patients with XFS/XFG, 95 POAG and 123 controls, and no significant differences were found at either low or high frequencies between groups after controlling for age, sex and possible confounders [ 72 ].…”
Section: Resultsmentioning
confidence: 84%
“…In contrast with the above-mentioned results, Muhafiz et al did not find any significant difference in hearing loss prevalence and hearing thresholds at 0.25, 0.5, 1, 2, 4, 6 and 8 kHz between XFS and controls ( p > 0.05) [ 71 ]. Additionally, Tryggvason et al examined hearing loss in 158 patients with XFS/XFG, 95 POAG and 123 controls, and no significant differences were found at either low or high frequencies between groups after controlling for age, sex and possible confounders [ 72 ].…”
Section: Resultsmentioning
confidence: 84%
“…Another study was excluded due to data being presented as graphs only, rather than meta‐analyzable numbers. However, the study found no difference in HL between patients with XFS and controls 57 . Two studies showed high a likelihood of reporting the same patients; both studies were included because they provided different types of primary outcomes data 46,47 .…”
Section: Resultsmentioning
confidence: 94%
“…However, the study found no difference in HL between patients with XFS and controls. 57 Two studies showed high a likelihood of reporting the same patients; both studies were included because they provided different types of primary outcomes data. 46,47 Patient data for these two studies were not doublecounted in any pooled statistics or meta-analyses.…”
Section: Resultsmentioning
confidence: 99%